• All
  • Executive Search
  • Finance
  • M&A
  • Views

'- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second...

Royalty income from licensed demineralized bone fiber technologies has surpassed $1.0m annually. LOS ANGELES, Nov. 20, 2020 /PRNewswire/ -- TheraCell Inc., a leading allograft solution company, today announced that as of September 30, 2020 its royalty income...